Cancer is a group of diseases that grow abnormal cells in the human body and can grow in any part of the body. Gene Therapy is a technique to prevent diseases, where the mutated genes are replaced by the specific genes causing the disease or are inactive in this gene. Cancer gene therapy is receiving high importance due to its high success rate during pre-clinical and clinical trials. The research and development on this are trying to replace the use of surgeries and drugs with gene therapy to treat cancer. The ongoing investment in research and development, and acceptance of gene therapy in cancer treatment is propelling this cancer gene therapy market during the forecast period. Biotechnology firms are increasing novel gene therapy vectors that increase levels of protein production or gene expansion, and reducing immunogenicity. According to National Center for Health Statistics, in 2023 there are 19,58,310 cancer cases in the U.S.

Further, the growing geriatric population, advanced product technology, increase in per capita disposable income, and emerging economies are the factors that are creating lucrative opportunities for the growing cancer gene therapy market.

Economic Impact of Covid-19:

The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pandemic era of the Global Cancer Gene Therapy Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs.

Key Players:

• Novartis AG
• Pfizer Inc.
• Amgen Inc
• Johnson & Johnson
• AstraZeneca
• GlaxoSmithKline plc
• Gilead Science, Inc.
• Abeona Therapeutics
• Altor Bioscience Inc.
• Celgene Inc.
• Introgen Therapeutics Inc.
• BioCancell Inc.
• Oncogenex
• Shanghai Sunway Biotech
• ZioPharm Oncology
• Others

The above key players in the Global Cancer Gene Therapy Market can be changed according to the client’s requirements.

Moreover, the key players aim towards expansion, joint ventures, collaboration, mergers, and acquisitions to advance capabilities in gene therapy.

Recent Developments in Global Cancer Gene Therapy Market.

In June 2023, OmniGene Therapeutics released positive data from a phase 2 clinical trial of their cancer gene therapy.

Global Cancer Gene Therapy Market Key Benefits:

1. The report provides information regarding key drivers, restraints, and opportunities with impact analysis.
2. Quantitative and Qualitative analysis of the current market.
3. Estimations for the forecast period 2032.
4. Historical data and forecast data.
5. Recent developments and trends in the market.   
6. Market share of the market players, company profiles, SWOT analysis, and competitive landscape.
7. Covid-19 Impact analysis

Global Cancer Gene Therapy Market Segmentation:

Based on Therapy:

• Gene Transfer
• Oncolytic Virotherapy
• Gene Induced Immunotherapy

Based on Indication:

• Breast Cancer
• Ovarian Cancer
• Lung Cancer
• Pancreatic Cancer
• Prostate Cancer
• Other

Based on End-User:

• Hospital
• Clinical Research Laboratories
• Oncology Institutes
• Biopharmaceutical companies

Based on Region:

Asia-Pacific

• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia-Pacific

North America

• US
• Canada
• Mexico

Europe

• Germany
• France
• Italy    
• Spain
• UK
• Rest of Europe

The rest of the World

Each of the market segments has been analysed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and competitive analysis.

Research Scope:

Report Scope	Details
Base Year	2023
Historical Years	2019 to 2022
Forecast Years	2023 to 2032
Market Size 2023	2.80 BN
Market Revenue 2032	15.3 BN
Growth Rate 2023- 2032	20.45%
Report Coverage	Trends, SWOT Analysis, Competitive Landscape, DROs, Revenue Forecast, PEST Analysis.
Segments Covered	Therapy, Indication, End-User, Region
Companies Mentioned	Novartis AG, Pfizer Inc., Amgen Inc., Johnson & Johnson, AstraZeneca, GlaxoSmithKline plc, Gilead Science, Inc., Abeona Therapeutics, Altor Bioscience Inc., Celgene Inc., Introgen Therapeutics Inc., BioCancell Inc., Oncogenex, Shanghai Sunway Biotech, ZioPharm Oncology
Customization	Yes

 

Key questions answered by this report.

1. Top market players contributing to the revenue?
2. Trending strategies by the players?
3. Which region will be the leading one in the forecast period?
4. Factors that drive the Global Cancer Gene Therapy Market?
5. Which factors will affect the Global Cancer Gene Therapy Market?
6. How Covid-19 pandemic impacted the growth of the Global Cancer Gene Therapy Market?
7. Which Segment accounted for the Global Cancer Gene Therapy Market shares?

Frequently Asked Questions (FAQ) :